• Generic competition hits AZ’ first-quarter sales pharmatimes
    May 24, 2018
    The drugs giant booked revenues of $5.2 billion for the quarter, marking a 4 percent drop from a year ago, or a 9 percent decline at constant exchange rates, while core operating profit plummeted 46 percent (47 percent CER) to $896 million.
PharmaSources Customer Service